| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6827564 | Schizophrenia Research | 2011 | 8 Pages |
Abstract
There were no significant differences in neurocognitive measures between adjunctive armodafinil and placebo in this 6-week study. Armodafinil improved anhedonia-asociality, but not other negative symptom domains.
Keywords
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
William V. Bobo, Neil D. Woodward, Min Young Sim, Karuna Jayathilake, Herbert Y. Meltzer,